Concepedia

A. Jeanson

AJ

Statistics

Publications

5

Citations

564

H-Index

5

Active since

1980

Affiliations

Aix-Marseille Université(Current)

Assistance Publique Hôpitaux de Marseille

Inserm

A. Jeanson is an author at Aix-Marseille Université specializing in immune checkpoint inhibitors, non-small cell lung cancer therapy, and immune checkpoint inhibitor therapy.

Publications per year

1980–2019

5

Publications

5

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

A. Jeanson, Pascale Tomasini, M. Souquet-Bressand et al. · Journal of Thoracic Oncology · 2019 · 229 citations · Full text

, , +14

Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non–small-cell Lung Cancer

M. Grangeon, Pascale Tomasini, S. Chaléat et al. · Clinical Lung Cancer · 2018 · 205 citations

, , +16

The action of leukotriene B4 (LTB4) on the lung

Pierré Sirois, P Borgeat, A. Jeanson et al. · Prostaglandins and Medicine · 1980 · 84 citations

, , +10

Comparative effects of leukotriene B4, prostaglandins I2 and E2, 6-keto-PGF1α, thromboxane B2 and histamine on selected smooth muscle preparations

Pierré Sirois, P Borgeat, A. Jeanson · Journal of Pharmacy and Pharmacology · 1981 · 32 citations

, , +8

MEDI 4736 (durvalumab) in non-small cell lung cancer

A. Jeanson, Fabrice Barlési · Expert Opinion on Biological Therapy · 2017 · 14 citations

, , +17

1–5 of 5